- CVS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $242.1 million.
- CVS has traded 106,859 shares today.
- CVS is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CVS with the Ticky from Trade-Ideas. See the FREE profile for CVS NOW at Trade-Ideas More details on CVS: CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The stock currently has a dividend yield of 1.4%. CVS has a PE ratio of 19.7. Currently there are 16 analysts that rate CVS Caremark a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for CVS Caremark has been 3.5 million shares per day over the past 30 days. CVS Caremark has a market cap of $93.1 billion and is part of the services sector and retail industry. The stock has a beta of 0.93 and a short float of 0.9% with 4.43 days to cover. Shares are up 12.2% year-to-date as of the close of trading on Thursday.
- The revenue growth came in higher than the industry average of 3.3%. Since the same quarter one year prior, revenues rose by 10.7%. Growth in the company's revenue appears to have helped boost the earnings per share.
- Investors have apparently begun to recognize positive factors similar to those we have mentioned in this report, including earnings growth. This has helped drive up the company's shares by a sharp 37.00% over the past year, a rise that has exceeded that of the S&P 500 Index. Regarding the stock's future course, although almost any stock can fall in a broad market decline, CVS should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- CVS HEALTH CORP has improved earnings per share by 16.5% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, CVS HEALTH CORP increased its bottom line by earning $3.76 versus $3.03 in the prior year. This year, the market expects an improvement in earnings ($4.49 versus $3.76).
- The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and the Food & Staples Retailing industry average. The net income increased by 11.2% when compared to the same quarter one year prior, going from $1,121.00 million to $1,246.00 million.
- The current debt-to-equity ratio, 0.35, is low and is below the industry average, implying that there has been successful management of debt levels. Despite the fact that CVS's debt-to-equity ratio is low, the quick ratio, which is currently 0.68, displays a potential problem in covering short-term cash needs.
- You can view the full CVS Caremark Ratings Report.